Research
OHNS Research Projects
Optical Imaging to Improve Surgery & Targeted Therapy in Brain Tumors (R01 pending review)
Improving Surgical Precision and Predicting Antibody delivery in Pancreatic Cancer (R01 pending review)
Dual-Modality Antibody Imaging for Precision Nodal Staging (R01 pending review)
Clinical Trial to Assess Benefit of Fluorescence-guided Head and Neck Cancer Surgery Phase II (submission in Feb 2019)
Adaptation and validation of DIGEST for FEES
Development and investigation of mobile technology as an adjunct to traditional swallowing therapy
Assessing the knowledge of head and neck cancer awareness in subjects with HIV
Normative values for percentage water content in neck tissue of normal individuals without lymphedema
Use of the G8 geriatric screening tool to identify high risk head and neck cancer patients
Swallowing outcomes in patients undergoing robotic head and neck surgery
Vasu Divi, MD / Lily Lam, NP
Promoting Self- Efficacy Among Head and Neck Cancer Survivors
Identification of Unknown Primary Carcinoma in Patients with Head & Neck Cancer: A Retrospective Study Evaluating the Clinical Implications, Outcomes, and Toxicity of Transoral Robotic Surgery (TORS) in the Multidisciplinary Treatment of Head and Neck Cancer of Unknown Primary
Hyperspectral Imaging of the Head and Neck
Cost Comparison of Treatments for Selected Oropharyngeal Carcinomas: Frontline Surgery Versus Radiation and Chemotherapy
Measure, Mark and Cut: The Importance of Consistent Margin Management
Robotic Head and Neck Surgery
Identification and Characterization of Novel Proteins and Genes in Head and Neck and/or Skin Cancer (SQL 76537
Whole Blood Specimen Collection From Healthy Volunteers
A Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Clinical Outcomes in Patients Undergoing Surgical Management for Hashimoto's Thyroiditis
Thyroid Cancer Care Collaborative Registry Protocol
Ultrasound Applications in Head & Neck Surgery
Defining Recurrent Versus Persistent Disease in Well-Differentiated Thyroid Cancer and the Importance of Delivering Appropriate Therap
A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy with the IRX-2 Regimen in Patients with Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity.